Cargando…
Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy
Background and study aims: Discontinuation of all antiplatelet agents before endoscopic procedures may cause serious complications in some patients. The aim of this study was to evaluate the hemorrhagic risk of post-endoscopic submucosal dissection (ESD) in patients on antiplatelet therapy (APT). Pa...
Autores principales: | Tounou, Shigetaka, Morita, Yasushi, Hosono, Tomohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423265/ https://www.ncbi.nlm.nih.gov/pubmed/26134769 http://dx.doi.org/10.1055/s-0034-1390764 |
Ejemplares similares
-
Endoscopic submucosal dissection for early gastric cancer without interruption of warfarin and aspirin
por: Tounou, Shigetaka, et al.
Publicado: (2015) -
Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study
por: Harada, Hideaki, et al.
Publicado: (2017) -
Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy
por: Harada, Hideaki, et al.
Publicado: (2019) -
Continued versus interrupted aspirin use and bleeding risk after endoscopic submucosal dissection of gastric neoplasms: a meta-analysis
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2018) -
Efficacy of vonoprazan for the prevention of bleeding after gastric endoscopic submucosal dissection with continuous use of antiplatelet agents
por: Yoshii, Shunsuke, et al.
Publicado: (2020)